Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) Debt to equity

Alert me on Debt to equity

Pfizer Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.7×, down 0.0× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.4× (fiscal 2022) to 0.8× (fiscal 2019); the current reading is higher than 82% of that period. That is above the Drug Manufacturers General industry median of 0.6× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.7× 2.68%
FY2024 0.7× (9.68%)
FY2023 0.8× 115.56%
FY2022 0.4× (24.73%)
FY2021 0.5× (20.94%)
FY2020 0.6× (23.64%)
FY2019 0.8× 25.54%
FY2018 0.7× 7.88%
FY2017 0.6× (13.71%)
FY2016 0.7× 17.51%

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.7× 3.67%
Mar 2026 0.7× (4.51%)
Dec 2025 0.7× 12.64%
Sep 2025 0.7× (4.52%)
42 more quarters

Against its own ten years

Low 0.4× High 0.8×
Ten-year median 0.7×
Current reading's percentile 82

Debt to equity against peers

Company Debt to equity
SNY Sanofi compare 0.3×
AZN AstraZeneca PLC compare 0.6×
NVO Novo Nordisk A/S compare 0.6×
PFE Pfizer Inc. 0.7×
GSK GSK PLC Sponsored ADR compare 1.1×
NVS Novartis AG compare 1.1×
BMY Bristol Myers Squibb Company compare 1.9×
GILD Gilead Sciences, Inc. compare 2.2×
AMGN Amgen Inc. compare 4.9×
Drug Manufacturers General industry median 0.6×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on PFE